Egyptian Drug Authority · Egypt
DEA-EG-2022-0024
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(24) For 2022
- Date issued
- 18 Oct 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Nexium 40mg 14 tabs Nexium 40mg 28 tabs
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- Not published with the notice
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٨١ أكتوبر٢٢٠٢
يتم ضبط وتحريز العبوات المقلدة من المستحضر التالي:
Nexium 40mg 14 tabs
Nexium 40mg 28 tabs
تعبئة: أسترازينيكا مصر
بتصريح من أسترازينيكا السويد
حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات غير الأصلية
للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة
المستحضر- كالآتي:
منشور
غش تجاري
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Nexium 40mg 14 tabs
Nexium 40mg 28 tabs
تعبئة: أسترازينيكا مصر
بتصريح من أسترازينيكا السويد
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Nexium 40mg 14 tabs
Nexium 40mg 28 tabs
تعبئة: أسترازينيكا مصر
بتصريح من أسترازينيكا السويدOriginal language: ar
- Notice text in English
- Egyptian Drug Authority trade-counterfeiting circular. Counterfeit packs of the following product are to be impounded and seized: Nexium 40mg 14 tablets and Nexium 40mg 28 tablets, packed by AstraZeneca Egypt under licence from AstraZeneca Sweden. Genuine and non-genuine packs of the product can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority. Dated 18 October 2022.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- df4a4635efd902d132de911a8ebe2df2ba00eceac143c9a4baffb1d3b1017874SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:10 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0024: Nexium 40mg 14 tabs Nexium 40mg 28 tabs — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0024Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.